Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Shares Issued (2023 - 2025)

Tonix Pharmaceuticals Holding (TNXP) has 3 years of Shares Issued data on record, last reported at $94.9 million in Q3 2025.

  • For Q3 2025, Shares Issued rose 117.54% year-over-year to $94.9 million; the TTM value through Sep 2025 reached $256.8 million, up 234.09%, while the annual FY2024 figure was $140.2 million, 521.1% up from the prior year.
  • Shares Issued reached $94.9 million in Q3 2025 per TNXP's latest filing, up from $13.9 million in the prior quarter.
  • Across five years, Shares Issued topped out at $94.9 million in Q3 2025 and bottomed at -$3.4 million in Q3 2023.
  • Average Shares Issued over 3 years is $30.3 million, with a median of $13.9 million recorded in 2025.
  • Peak YoY movement for Shares Issued: fell 20.69% in 2024, then soared 270465.22% in 2025.
  • A 3-year view of Shares Issued shows it stood at $22.5 million in 2023, then skyrocketed by 280.87% to $85.9 million in 2024, then grew by 10.48% to $94.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were $94.9 million in Q3 2025, $13.9 million in Q2 2025, and $62.2 million in Q1 2025.